B
Biofourmis
Biotech & Life Sciences · Boston, United States · Founded 2015 Unicorn
Global footprint
Where Biofourmis has talent and traffic
(2 of 114 staff)
team presence
across markets
Capital deployed
Biofourmis's 3 investments and acquisitions.
Every disclosed deal where Biofourmis appeared as a backer or acquirer, 2019–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Biofourmis's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Biofourmis's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Biofourmis
An AI-synthesized read of the highest-engagement posts about Biofourmis on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biofourmis on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.